Thymalin as an immunomodulation option in severe COVID-19

被引：1
|
作者：
Lukyanov, Sergey [1 ]
Shapovalov, Konstantine [1 ]
Tereshkov, Pavel [1 ]
Smolyakov, Yuri [1 ]
Vanchikova, Ayagma [1 ]
Kuznik, Boris [1 ]
机构：
[1] Chita State Med Acad, Chita Zabaykalsky Krai, Moscow, Russia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Covid-19; Critically ill patients; Immunosuppression;
D O I：
10.1183/13993003.congress-2021.PA3667
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3667
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical research and COVID-19: science is not an option
    不详
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (07): : 710 - 711
  • [42] Stem cells as an option for the treatment of COVID-19
    Maria Veronica Cuevas-González
    Juan Carlos Cuevas-González
    [J]. World Journal of Clinical Cases, 2022, 10 (18) : 6338 - 6340
  • [43] Stem cells as an option for the treatment of COVID-19
    Veronica Cuevas-Gonzalez, Maria
    Carlos Cuevas-Gonzalez, Juan
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (18) : 6338 - 6340
  • [44] Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report
    Caroline Streicher
    Xavier Engalenc
    Marion Gaudin
    Guillaume Vignaud
    Annick Daulange
    Bruno Abraham
    [J]. Clinical Drug Investigation, 2020, 40 : 1085 - 1088
  • [45] D-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19
    Kimura-Ohba, Shihoko
    Asaka, Masamitsu N.
    Utsumi, Daichi
    Takabatake, Yoshitsugu
    Takahashi, Atsushi
    Yasutomi, Yasuhiro
    Isaka, Yoshitaka
    Kimura, Tomonori
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (01):
  • [46] Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report
    Streicher, Caroline
    Engalenc, Xavier
    Gaudin, Marion
    Vignaud, Guillaume
    Daulange, Annick
    Abraham, Bruno
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (11) : 1085 - 1088
  • [47] Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?
    Singh, Harmanjit
    Chauhan, Prerna
    Singh, Jasbir
    Saurabh, Saurabh
    Gautam, C. S.
    Kakkar, Ashish Kumar
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (03) : 315 - 322
  • [48] Clinical Outcomes and Survival Analysis of Remdesivir as a Treatment Option for Moderate to Severe COVID-19 Patients
    Aboelsaad, Iman
    Ashmawy, Rasha
    Mahrous, Doaa
    Sharaf, Sandy
    Aly, Shahinda
    Abdullatif, Sara
    Fakhry, Ayat
    Hassan, Basma
    Khamis, Dalia
    Aldakhs, Alaa
    Kamal, Ehab
    [J]. COVID, 2022, 2 (12): : 1758 - 1767
  • [49] Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
    Hertanto, Decsa Medika
    Wiratama, Bayu Satria
    Sutanto, Henry
    Wungu, Citrawati Dyah Kencono
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3419 - 3428
  • [50] The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19
    Lai, Yu-Ju
    Chang, Huan-Shuo
    Yang, Yi-Ping
    Lin, Tzu-Wei
    Lai, Wei-Yi
    Lin, Yi-Ying
    Chang, Cheng-Chang
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (09) : 821 - 826
12345